Breaking News Instant updates and real-time market news.

PCRX

Pacira

$38.06

-2.02 (-5.04%)

04:55
10/01/19
10/01
04:55
10/01/19
04:55

Pacira management to meet with RBC Capital

Meeting to be held in New York on October 1 hosted by RBC Capital.

  • 01

    Oct

  • 03

    Oct

PCRX Pacira
$38.06

-2.02 (-5.04%)

05/02/19
STFL
05/02/19
UPGRADE
Target $45
STFL
Hold
Stifel upgrades Pacira to Hold after Heron competition delayed
As previously reported, Stifel analyst Derek Archila upgraded Pacira (PCRX) to Hold from Sell after Heron Therapeutics (HRTX) announced yesterday that it received a Complete Response Letter from the FDA for its New Drug Application for HTX-011 for the management of postoperative pain. Archila now forecasts HTX-011's approval and launch in 2020 and thinks Pacira's Exparel will likely remain the only local, non-opioid, long-acting analgesic on the market through the remainder of 2019. He also believes a recent price increase and a favorable reimbursement scheme in the ASC setting should set the company up to achieve its 2019 Exparel guidance. However, Archila said key points from his Sell thesis still worry him long-term as he thinks other more competitive offerings, from Heron and others, will eventually come to market. Given his increased Exparel forecast and the incorporation of the recent acquisition of Iovera, Archila raised his price target on Pacira shares to $45 from $33.
05/06/19
MZHO
05/06/19
UPGRADE
Target $38
MZHO
Neutral
Pacira upgraded to Neutral from Underperform at Mizuho
Mizuho analyst Irina Koffler upgraded Pacira Biosciences (PCRX) to Neutral from Underperform and raised her price target for the shares to $38 from $29. The analyst says her sell thesis on the shares is longer valid due to an unexpected delay at competitor Heron Therapeutics (HRTX) and Pacira's stronger guidance on recently acquired iovera. However, she still remains concerned about the longer-term outlook for the company.
05/30/19
JEFF
05/30/19
NO CHANGE
Target $37
JEFF
Buy
Heron Therapeutics target raised to $37 after doctor survey at Jefferies
Jefferies analyst Biren Amin raised his price target for Heron Therapeutics (HRTX) to $37 from $35 after conducting an expert survey prior to the company's FDA action date. The analyst's survey of 50 U.S. doctors suggests HTX-011 would capture the majority of its share from generic bupivacaine, with the remainder from Pacira's (PCRX) Exparel. Importantly, doctors view the opioid-sparing effect of TX-011 as compelling, Amin tells investors in a research note. HE keeps a Buy rating on the shares.
06/11/19
LEHM
06/11/19
INITIATION
Target $52
LEHM
Overweight
Pacira initiated with an Overweight at Barclays
Barclays analyst Balaji Prasad started Pacira BioSciences with an Overweight rating and $52 price target. The analyst launched coverage of 20 U.S. Specialty Pharmaceuticals with a Neutral industry view. He placed importance on cash flows and companies' ability to manage leverage and improve balance sheets.

TODAY'S FREE FLY STORIES

HFC

HollyFrontier

$52.56

-1.31 (-2.43%)

06:42
11/18/19
11/18
06:42
11/18/19
06:42
Hot Stocks
HollyFrontier targets expected dividend growth rate of ~5% per year »

Over the next three…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CREE

Cree

$48.74

1.3 (2.74%)

06:42
11/18/19
11/18
06:42
11/18/19
06:42
Conference/Events
Cree to host investor day »

Investor day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

BA

Boeing

$371.55

4.25 (1.16%)

06:42
11/18/19
11/18
06:42
11/18/19
06:42
Periodicals
FAA considers certification changes following Boeing 737 Max crashes, WSJ says »

Federal Aviation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HFC

HollyFrontier

$52.56

-1.31 (-2.43%)

06:41
11/18/19
11/18
06:41
11/18/19
06:41
Hot Stocks
HollyFrontier to construct new RDU at its Artesia refinery »

HollyFrontier plans to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HFC

HollyFrontier

$52.56

-1.31 (-2.43%)

06:40
11/18/19
11/18
06:40
11/18/19
06:40
Hot Stocks
HollyFrontier announces $1B share repurchase program »

HollyFrontier's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JD

JD.com

$33.53

-0.04 (-0.12%)

06:40
11/18/19
11/18
06:40
11/18/19
06:40
Recommendations
JD.com analyst commentary  »

JD.com price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

AVLR

Avalara

$72.36

0.24 (0.33%)

, GE

General Electric

$11.51

0.21 (1.86%)

06:38
11/18/19
11/18
06:38
11/18/19
06:38
Hot Stocks
Avalara names Jay Lee as Chief Marketing Officer »

Avalara (AVLR) announced…

AVLR

Avalara

$72.36

0.24 (0.33%)

GE

General Electric

$11.51

0.21 (1.86%)

AXP

American Express

$120.77

-0.18 (-0.15%)

PYPL

PayPal

$104.21

0.41 (0.39%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 20

    Nov

  • 21

    Nov

  • 02

    Dec

  • 06

    Dec

  • 09

    Dec

  • 10

    Dec

  • 29

    Jan

TRMB

Trimble

$39.64

0.44 (1.12%)

, STN

Stantec

$26.43

0.41 (1.58%)

06:36
11/18/19
11/18
06:36
11/18/19
06:36
Hot Stocks
Trimble announces David Barnes as new CFO »

Trimble (TRMB) announced…

TRMB

Trimble

$39.64

0.44 (1.12%)

STN

Stantec

$26.43

0.41 (1.58%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SURF

Surface Oncology

$1.80

-0.05 (-2.70%)

06:36
11/18/19
11/18
06:36
11/18/19
06:36
Hot Stocks
Surface Oncology files IND for CD39 targeted antibody candidate, SRF617 »

Surface Oncology…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Nov

06:35
11/18/19
11/18
06:35
11/18/19
06:35
General news
FX Update: Sterling has rallied on weekend polls »

FX Update: Sterling has…

AL

Air Lease

$45.48

0.36 (0.80%)

, EADSY

Airbus

$0.00

(0.00%)

06:35
11/18/19
11/18
06:35
11/18/19
06:35
Hot Stocks
Air Lease announces lease placement of six Airbus A321-200 with Air Transat »

Air Lease (AL) announced…

AL

Air Lease

$45.48

0.36 (0.80%)

EADSY

Airbus

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TNK

Teekay Tankers

$2.39

0.155 (6.94%)

06:34
11/18/19
11/18
06:34
11/18/19
06:34
Upgrade
Teekay Tankers rating change  »

Teekay Tankers upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AERI

Aerie Pharmaceuticals

$18.93

0.715 (3.93%)

06:33
11/18/19
11/18
06:33
11/18/19
06:33
Hot Stocks
Aerie Pharmaceuticals to acquire Avizorex Pharma, S.L. in all-cash deal »

Aerie Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OC

Owens Corning

$65.18

0.225 (0.35%)

06:32
11/18/19
11/18
06:32
11/18/19
06:32
Upgrade
Owens Corning rating change  »

Owens Corning upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRK

Merck

$84.89

0.33 (0.39%)

, BAYRY

Bayer

$0.00

(0.00%)

06:32
11/18/19
11/18
06:32
11/18/19
06:32
Hot Stocks
Merck, Bayer's vericiguat meets primary endpoint in Phase 3 study »

Merck (MRK) announced…

MRK

Merck

$84.89

0.33 (0.39%)

BAYRY

Bayer

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Nov

  • 07

    Dec

  • 10

    Dec

  • 24

    Jan

  • 24

    Jan

  • 05

    Feb

  • 14

    Mar

ATTO

Atento

$2.83

0.04 (1.43%)

06:32
11/18/19
11/18
06:32
11/18/19
06:32
Conference/Events
Atento to host investor day »

Investor day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Nov

AERI

Aerie Pharmaceuticals

$18.93

0.715 (3.93%)

06:30
11/18/19
11/18
06:30
11/18/19
06:30
Hot Stocks
Breaking Hot Stocks news story on Aerie Pharmaceuticals »

Aerie Pharmaceuticals to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KEYS

Keysight Technologies

$109.08

2.26 (2.12%)

06:30
11/18/19
11/18
06:30
11/18/19
06:30
Initiation
Keysight Technologies initiated  »

Keysight Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

BRP

BRP Group

$17.47

-0.03 (-0.17%)

06:29
11/18/19
11/18
06:29
11/18/19
06:29
Initiation
BRP Group initiated  »

BRP Group initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SURF

Surface Oncology

$1.80

-0.05 (-2.70%)

06:28
11/18/19
11/18
06:28
11/18/19
06:28
Conference/Events
Surface Oncology to host analyst & investor day »

Analyst & Investor…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Nov

MGY

Magnolia Oil & Gas

$11.69

0.07 (0.60%)

06:28
11/18/19
11/18
06:28
11/18/19
06:28
Initiation
Magnolia Oil & Gas initiated  »

Magnolia Oil & Gas…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$265.73

3.07 (1.17%)

, SSNLF

Samsung

$0.00

(0.00%)

06:27
11/18/19
11/18
06:27
11/18/19
06:27
Periodicals
Apple expected to capture top spot in 5G smartphone race in 2020, DigiTimes says »

Apple (AAPL) is expected…

AAPL

Apple

$265.73

3.07 (1.17%)

SSNLF

Samsung

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ANCN

Anchiano Therapeutics

$1.93

-0.32 (-14.22%)

06:26
11/18/19
11/18
06:26
11/18/19
06:26
Downgrade
Anchiano Therapeutics rating change  »

Anchiano Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LEG

Leggett & Platt

$53.36

0.16 (0.30%)

06:26
11/18/19
11/18
06:26
11/18/19
06:26
Conference/Events
Leggett & Platt to host investor day »

Investor day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Nov

  • 19

    Nov

SRPT

Sarepta

$97.42

-0.03 (-0.03%)

, SLDB

Solid Biosciences

$3.51

0.37 (11.78%)

06:26
11/18/19
11/18
06:26
11/18/19
06:26
Recommendations
Sarepta, Solid Biosciences analyst commentary  »

Sarepta price target…

SRPT

Sarepta

$97.42

-0.03 (-0.03%)

SLDB

Solid Biosciences

$3.51

0.37 (11.78%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.